19 Facts About Actelion


Actelion is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland.

FactSnippet No. 870,569

Actelion focuses on the manufacture of drugs that treat rare diseases and orphan diseases.

FactSnippet No. 870,570

One of the focuses of Actelion is treating individuals with pulmonary arterial hypertension, a heart condition that leaves patients with a short life expectancy even with treatment.

FactSnippet No. 870,571

Actelion scientists were among the first to work in the field of endothelian receptor antagonists.

FactSnippet No. 870,572

Actelion was initially financed with venture capital provided through a syndicate including Atlas Venture, Sofinnova and HealthCap.

FactSnippet No. 870,573

Actelion develops and sells drugs in the continents of Asia, Europe and North and South America.

FactSnippet No. 870,574

Actelion has 29 operative affiliates around the world, including in the United States, Canada, Brazil, Australia, Japan, Switzerland and a number of EU countries.

FactSnippet No. 870,575

Actelion was founded in 1997 by husband and wife team Jean-Paul and Martine Clozel together with three colleagues after F Hoffmann-La Roche cut their funding for Martine's cardiovascular program.

FactSnippet No. 870,576

In November 2006, CoTherix and Actelion signed a merger plan, which was announced publicly; this followed the initiation of negotiations in August 2006.

FactSnippet No. 870,577

In January 2007, Actelion completed acquisition of all CoTherix stock, and summarily informed Asahi that work on fasudil would be terminated.

FactSnippet No. 870,578

Now, Actelion had a competitor blockbuster drug on the market, bosentan .

FactSnippet No. 870,579

Actelion was able to do this by illegally providing money to Medicare patients in order for them to be able to fulfill their co-payments for the drug Tracleer.

FactSnippet No. 870,580

Actelion was able to use the charity organization by the name of Caring Voice Coalition to send money only to those people who were receiving prescriptions of Tracleer.

FactSnippet No. 870,581

Actelion was complicit in referring patients to Caring Voice Coalition.

FactSnippet No. 870,582

Actelion has been reported to start working with Analytics 4 Life to use imaging technology with regards to pulmonary hypertension.

FactSnippet No. 870,583

Actelion currently has 10 compounds in its pipeline – including 3 in late-stage development – and 4 medicines on the market for orphan diseases:.

FactSnippet No. 870,584

Actelion's shares have been listed on the SIX Swiss Exchange since 2000 SWX Swiss Exchange Swiss Leader Index.

FactSnippet No. 870,585

In September 2008, Actelion shares began trading as part of the Swiss Market Index.

FactSnippet No. 870,586

Actelion received the "Prix Hermes de l'innovation" in April 2011: The "European Institute for Creative Strategy and Innovation", the creator of the Prix Hermes, was founded in 2003 in France.

FactSnippet No. 870,587